Michael Sheehan, MD
Dermatology · Columbus, INNPI 1134388119
Payments from drug & device makers
Across 646 payments — averaging $587.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$104K
- Regeneron Healthcare Solutions, Inc.$85K
- Sanofi US Services Inc.$65K
- Sanofi$39K
- Amgen$33K
- Bristol Myers Squibb$30K
- plus $24K from 27 others
Across 1 payment — averaging $2952.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3K
What the payments were for
- Consulting fees$6,9922%
- Speaking & faculty fees$260,60288%
- Travel & lodging$16,3656%
- Food & beverage$12,6204%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 183 | $103,561 |
| Regeneron Healthcare Solutions, Inc. | 82 | $85,376 |
| Sanofi US Services Inc. | 8 | $65,210 |
| Sanofi | 44 | $38,950 |
| Amgen | 59 | $32,592 |
| Bristol Myers Squibb | 32 | $29,625 |
| Eli Lilly | 1 | $17,596 |
| Pfizer | 24 | $2,370 |
| Johnson & Johnson | 30 | $570 |
| Lilly USA, LLC | 27 | $558 |
| Novartis | 50 | $540 |
| UCB, Inc. | 16 | $509 |
| Galderma Laboratories, L.p. | 17 | $391 |
| E.r. Squibb & Sons, L.L.C. | 14 | $313 |
| Sun Pharmaceutical Industries Inc. | 14 | $232 |
| LEO Pharma Inc. | 11 | $176 |
| Incyte Corporation | 4 | $173 |
| Strata Skin Sciences, Inc. | 3 | $121 |
| Genentech USA, Inc. | 2 | $113 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $66 |
| Mallinckrodt Hospital Products Inc. | 2 | $58 |
| Boehringer Ingelheim | 3 | $57 |
| Journey Medical Corporation | 2 | $40 |
| VYNE Pharmaceuticals Inc. | 2 | $35 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Dermavant Sciences, Inc. | 2 | $34 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $23 |
| Botanix SB Inc | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $14 |
| Almirall LLC | 1 | $13 |
| Prugen, Inc. Pharmaceuticals | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$379,478 in reported general payments places this provider in the 90th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 20 | $197,317 |
| Dupixent PenDupilumab | 36 | $160,555 |
| Taltz AutoinjectorIxekizumab | 11 | $74,089 |
| Doxycycline Monohydrate | 316 | $8,475 |
| Fluorouracil | 91 | $7,562 |
| Tacrolimus | 61 | $7,324 |
| Acitretin | 14 | $6,531 |
| Clobetasol Propionate | 108 | $5,538 |
| Ketoconazole | 330 | $5,138 |
| Desoximetasone | 46 | $4,541 |
| Metronidazole | 84 | $4,402 |
| Triamcinolone Acetonide | 258 | $3,101 |
| Betamethasone Dipropionate | 59 | $2,942 |
| Mycophenolate Mofetil | 27 | $1,852 |
| Doxepin Hcl | 57 | $1,598 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Columbus
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Holly Hake HarrisSouth Bend$3.4M
- Megan LandisCorydon$2.8M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
- Vassilios DimitropoulosMichigan City$1.8M
- Christopher ObeimeIndianapolis$907K
- Megan VissingNew Albany$884K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.